Vigeo Therapeutics
PrivateLast Round
Series C
Mar 10, 2021
Total Funding Raised
$62.58M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Vigeo Therapeutics is a biotechnology company that develops novel therapeutics for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vigeo Therapeutics Comparables
Compare Vigeo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 80% | |
| Bexion Pharmaceuticals | 78% | |
| Imvax | 77% | |
Vigeo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 10, 2021 | ||||
| Series B | Dec 19, 2018 | ||||
| Series A | Nov 15, 2017 | ||||
| Series A | Jun 12, 2015 |
Vigeo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A, Series B |
| Morningside Group | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 9, 180% of current headcount.
- Mar 25, 2021
Raised $8 million in debt financing.
Vigeo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vigeo Therapeutics's valuation, stock price, and market status.